Compare TTMI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTMI | ICLR |
|---|---|---|
| Founded | 1978 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 8.2B |
| IPO Year | 2000 | 2001 |
| Metric | TTMI | ICLR |
|---|---|---|
| Price | $137.02 | $101.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $118.50 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 211.11 | N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | ★ $2,906,345,000.00 | N/A |
| Revenue This Year | $18.60 | N/A |
| Revenue Next Year | $16.91 | N/A |
| P/E Ratio | $85.67 | ★ $12.91 |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $19.59 | $66.57 |
| 52 Week High | $149.00 | $211.00 |
| Indicator | TTMI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 65.56 | 38.82 |
| Support Level | $87.36 | $95.75 |
| Resistance Level | N/A | $114.75 |
| Average True Range (ATR) | 8.16 | 4.73 |
| MACD | 2.34 | -1.11 |
| Stochastic Oscillator | 73.22 | 10.08 |
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.